Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.

Thrombosis and haemostasis - 1 Jan 2016

Suchon Pierre, Al Frouh Fadi, Henneuse Agathe, Ibrahim Manal, Brunet Dominique, Barthet Marie-Christine, Aillaud Marie-Françoise, Venton Geoffroy, Alessi Marie-Christine, Trégouët David-Alexandre, Morange Pierre-Emmanuel

Abstract excerpt

Identifying women at risk of venous thromboembolism (VTE) is a major public health issue. The objective of this study was to identify environmental and genetic determinants of VTE risk in a large sample of women under combined oral contraceptives (COC). A total of 968 women who had had one event of VTE during COC use were compared to 874 women under COC but with no personal history of VTE. Clinical data were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ABO Blood-Group System
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to Contraceptives, Oral, Hormonal

Share to France

Share to Multivariate Analysis

Share to Thrombophilia

Share to Venous Thromboembolism

Source

Identifiers

PMID: 26290123
DOI: 10.1160/TH15-01-0045

Genes

ABO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.PMID 26290123Read ↗

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study.Semantic proximity Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk.Semantic proximity Read ↗

Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk.Semantic proximity Read ↗

Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors.Semantic proximity Read ↗

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.Semantic proximity Read ↗

Venous thromboembolism and ovarian cancer risk: a Mendelian randomized studySemantic proximity Read ↗

Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.Semantic proximity Read ↗

Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.Semantic proximity Read ↗

Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous ThromboembolismSemantic proximity Read ↗

Risk factors for venous thromboembolism in pre-and postmenopausal women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.